CDH Proton Center expands treatment capacity

NewsGuard 100/100 Score

The CDH Proton Center, A ProCure Center, in suburban Chicago, is now able to treat a wider variety of cancer tumors with the opening of a treatment room with a gantry, a nearly 100-ton rotating steel wheel that allows the proton beam to be directed at the tumor from any angle. Opening the gantry expands the number and types of patients the Center can treat with proton therapy, an alternative to standard X-ray radiation for cancer that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

“With an estimated 11,000 Illinois residents this year alone who stand to benefit from proton therapy, the need for this advanced treatment is great.”

"The opening of this, our third treatment room is great news for patients who could benefit from proton therapy," said William Hartsell, M.D., medical director of the CDH Proton Center, A ProCure Center. "The gantry in particular allows us to treat more clinically challenging tumors because the proton beam can be very precisely rotated 360 degrees around the patient."

The Center, which opened in October 2010, has four treatment rooms and will be able to treat up to 1,500 patients per year when all four are open. The Center plans to start operating a second shift to accommodate more patients in the rooms already open before commissioning the fourth and final room.

"The opening of the gantry room brings us one step closer to helping as many patients with cancer as possible in Illinois and the surrounding region," said James R. Williams, president of the CDH Proton Center, A ProCure Center. "With an estimated 11,000 Illinois residents this year alone who stand to benefit from proton therapy, the need for this advanced treatment is great."

Source:

CDH Proton Center, A ProCure Center

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis